Dulaglutide as treatment escalation of SGLT2 in type 2 diabetes: The AWARD-10 trial
This 3rd in a series of 3 Study Briefs summarises the key findings from the AWARD-10 clinical trials, featuring expert advice from Dr Roy Rasalam to help you optimise your practice.
Sign up for free and continue reading
Med CPD offers the widest range of courses and content, all accessible in one place. Click on the Sign up button and start looking after the health of your career.
Other courses
Become a Med CPD member for free, and the rest comes easy.
Quality Education From
![Meaningful Ageing Australia](https://medcpd.com/wp-content/uploads/2023/01/Meaningful-Ageing-Australia.png)
![Digital Health Festival](https://medcpd.com/wp-content/uploads/2023/01/Digital-Health-Festival.png)
![Avant](https://medcpd.com/wp-content/uploads/2023/01/Avant.png)
![Standout Medical Careers](https://medcpd.com/wp-content/uploads/2023/01/Standout-Medical-Careers.png)
![Immunisation Coalition](https://medcpd.com/wp-content/uploads/2023/01/Immunisation-Coalition.png)
![Meaningful Ageing Australia](https://medcpd.com/wp-content/uploads/2023/01/Meaningful-Ageing-Australia.png)
![Digital Health Festival](https://medcpd.com/wp-content/uploads/2023/01/Digital-Health-Festival.png)
![Avant](https://medcpd.com/wp-content/uploads/2023/01/Avant.png)
![Standout Medical Careers](https://medcpd.com/wp-content/uploads/2023/01/Standout-Medical-Careers.png)
![Immunisation Coalition](https://medcpd.com/wp-content/uploads/2023/01/Immunisation-Coalition.png)